SANJIVANI PARANTERAL
|
SANJIVANI PARANTERAL Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | |
|---|---|---|---|
| Profit Before Tax | ₹9.39 Cr | ₹10 Cr | ₹7.57 Cr |
| Adjustment | ₹1.95 Cr | ₹0.73 Cr | ₹0.77 Cr |
| Changes In working Capital | ₹-9.33 Cr | ₹2.64 Cr | ₹-18 Cr |
| Cash Flow after changes in Working Capital | ₹2.02 Cr | ₹14 Cr | ₹-9.59 Cr |
| Cash Flow from Operating Activities | ₹-0.11 Cr | ₹12 Cr | ₹-11 Cr |
| Cash Flow from Investing Activities | ₹-9.97 Cr | ₹-22 Cr | ₹-12 Cr |
| Cash Flow from Financing Activities | ₹9.84 Cr | ₹10 Cr | ₹23 Cr |
| Net Cash Inflow / Outflow | ₹-0.24 Cr | ₹0.94 Cr | ₹0.24 Cr |
| Opening Cash & Cash Equivalents | ₹1.49 Cr | ₹0.54 Cr | ₹0.30 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹1.24 Cr | ₹1.49 Cr | ₹0.54 Cr |
Compare Cashflow Statement of peers of SANJIVANI PARANTERAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANJIVANI PARANTERAL | ₹213.8 Cr | 9.8% | 1.6% | -15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | 9.8% |
1.6% |
-15.7% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses